Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

What's Behind the Latest Move in Careteq (ASX:CTQ)?

Careteq returned to investor watchlists on 9 June after its shares gained 8.33% to AUD 0.013. The move left the stock trading close to its 52-week high of AUD 0.014 and lifted the company's market capitalisation to approximately AUD 11.4 million.

Aditi Sarkar | 09 June 2026

Resonance Health (ASX:RHT) Shares Rose 10% as Investors Revisit Medical Imaging Technology

Resonance Health returned to investor watchlists after its shares climbed 10.00% to AUD 0.044 on 9 June. The move lifted the company's market capitalisation to approximately AUD 21.0 million and placed it among the stronger-performing small-cap healthcare stocks during the session.

Aditi Sarkar | 09 June 2026

Vitrafy Life Sciences (ASX:VFY) Shares Hit 52-Week High on Jumping 11%

Vitrafy Life Sciences attracted renewed investor interest on 9 June after its shares climbed 10.77% to AUD 3.60, matching the company's 52-week high. The move lifted its market capitalisation to approximately AUD 179.8 million and placed it among the day's stronger-performing healthcare stocks on …

Aditi Sarkar | 09 June 2026

Clever Culture Systems (ASX:CC5) Back in Focus After Renewed Trading Activity

Clever Culture Systems returned to investor watchlists after its shares climbed 10.00% to AUD 0.022 on 9 June. The move lifted the healthcare technology company's market capitalisation to approximately AUD 48.0 million and placed it among the stronger-performing small-cap healthcare stocks during the session.

Aditi Sarkar | 09 June 2026

Rhythm Biosciences (ASX:RHY) Shares Climb 14%: Here's What Investors Are Watching

Rhythm Biosciences Ltd returned to investor watchlists after its shares gained 14.29% to AUD 0.12 on 9 June. The move lifted the healthcare company'sMarket Capitalisationto approximately AUD 40.5 million and placed it among the stronger performers in the small-cap healthcare sector.

Aditi Sarkar | 09 June 2026

Alterity Therapeutics (ASX:ATH) Shares Surge 19%: What's Driving Interest?

Alterity Therapeutics attracted renewed investor attention after its shares jumped 19.05% to AUD 0.50 on 9 June. The move lifted the biotechnology company's market capitalisation to approximately AUD 91.4 million and placed it among the stronger performers in the healthcare sector.

Aditi Sarkar | 09 June 2026

Imugene (ASX:IMU) Shares Rally as FDA Grants Special Status to Lead Cancer Therapy

Imugene Ltd (ASX:IMU) attracted investor attention on 9 June 2026 after announcing that the U.S. Food and Drug Administration (FDA) had granted Fast Track Designation to its lead cell therapy candidate, azer-cel, for two blood cancer indications.

Aditi Sarkar | 09 June 2026

ELV Completes Share Purchase Plan as Investors Watch Funding Momentum

The company trading underASX CodeELV has stayed firmly in focus for investors, with traders watching closely for the next development in its story. The company trading under ASX code ELV has drawn attention after completing a share-purchase plan, a common funding step for smaller …

Aditi Sarkar | 05 June 2026

PainChek's (ASX:PCK) New Chair Steps Into Focus as Health-Tech Investors Watch

PainChek (ASX:PCK) has stayed firmly in focus for investors, with traders watching closely for the next development in its story. PainChek (ASX: PCK) has developed a regulatory-cleared digital tool that uses facial-analysis technology to assess pain in people who cannot reliably self-report.

Aditi Sarkar | 05 June 2026

Why Are Investors Watching Singular Health’s (ASX: SHG) U.S. Expansion?

Singular Health Group Limited (ASX: SHG) has seen renewed investor focus in recent months as trading activity in the stock picked up and attention grew around the company's 3D medical imaging and visualisation software platform. This attention is being driven by operational milestones, regulatory …

Shwetambri Chauhan | 05 June 2026
Support

Hi! How can we help you today?

Loading…